Advertisement

World Journal of Pediatrics

, Volume 13, Issue 1, pp 20–26 | Cite as

Adjuvant steroid treatment following Kasai portoenterostomy and clinical outcomes of biliary atresia patients: an updated meta-analysis

  • Min-Zhong Zhang
  • Peng-Cheng Xun
  • Ka He
  • Wei Cai
Meta-analysis

Abstract

Background

It is controversial whether adjuvant steroid treatment should be given to biliary atresia (BA) patients following a Kasai portoenterostomy (KPE). This study aimed to quantitatively and systematically evaluate the effect of adjuvant steroid therapy post-KPE in relation to major clinical outcomes of BA patients.

Methods

We systematically reviewed the literature in PubMed, Embase, the Cochrane Library, China Knowledge Resource Integrated Database, Wanfang Database, Scholarly and Academic Information Navigator and manually searched for relevant papers published before August, 2015. We extracted data on the effects of steroid treatment following KPE on clinical outcome, including jaundice free rate and native liver survival rate at 6 months, 1 or 2 years after KPE. The weighted overall relative risk (RR) and 95% confidence intervals (CIs) were calculated by using a random-effects model.

Results

Eight cohort studies and two randomized controlled trials (RCTs) were identified (n=998). Of them, 6 cohort studies and 2 trials investigated the effect of steroid treatment as compared to non-users or placebo (n=566), and 2 cohort studies compared the effects of high-dose to low-dose steroid treatment (n=432). Steroid usage increased the clearance rates of jaundice at 6 months (pooled RR: 1.32; 95% CI: 0.995-1.76; I2=72.6%) and 1 year (pooled RR: 1.35; 95% CI: 1.12-1.61; I2=0.0%), but not 2 years (pooled RR: 0.82; 95% CI: 0.55-1.22; I2=0.0%) after KPE. There was no solid evidence supporting that steroid treatment would improve native liver survival rate at 6 months (pooled RR: 1.02; 95% CI: 0.90-1.15; I2=0.0%), 1 year (pooled RR: 1.10; 95% CI: 0.91-1.34; I2=35.2%) or 2 years (pooled RR: 1.00; 95% CI: 0.73-1.35; I2=57.4%) after KPE.

Conclusions

Adjuvant steroid treatment following KPE may improve short-term (≤1 year) clearance rate of jaundice, but no significant effects on long-term (≥2 years) clearance rate of jaundice and native liver survival rate. Studies on doses and duration of steroids, and long-term follow-up studies are warranted.

Key words

biliary atresia Kasai portoenterostomy steroid treatment 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Acknowledgements

The work was supported by Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition. The authors thank all the colleagues for their support on this research.

References

  1. 1.
    Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet 2009;374:1704–1713.CrossRefPubMedGoogle Scholar
  2. 2.
    Kasai M, Kimura S, Asakura Y, Suzuki H, Taira Y, Ohashi E. Surgical treatment of biliary atresia. J Pediatr Surg 1968;3:665–675.CrossRefGoogle Scholar
  3. 3.
    Altman RP, Anderson KD. Surgical management of intrac+cholangitis following successful Kasai procedure. J Pediatr Surg 1982;17:894–900.CrossRefPubMedGoogle Scholar
  4. 4.
    Sarkhy A, Schreiber RA, Milner R, Barker CC. Does adjuvant steroid therapy post-Kasai portoenterostomy improve outcome of biliary atresia? Systematic review and meta-analysis. Can J Gastroenterol 2011;25:440–444.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Zhang D, Yang HY, Jia J, Zhao G, Yue M, Wang JX. Postoperative steroids after Kasai portoenterostomy for biliary atresia: A meta-analysis. Int J Surg 2014;12:1203–1209.CrossRefPubMedGoogle Scholar
  6. 6.
    Bezerra JA, Spino C, Magee JC, Shneider BL, Rosenthal P, Wang KS, et al. Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial. JAMA 2014;311:1750–1759.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Davenport M, Parsons C, Tizzard S, Hadzic N. Steroids in biliary atresia: single surgeon, single centre, prospective study. J Hepatol 2013;59:1054–1058.CrossRefPubMedGoogle Scholar
  8. 8.
    Chen Y, Nah SA, Chiang L, Krishnaswamy G, Low Y. Postoperative steroid therapy for biliary atresia: Systematic review and meta-analysis. J Pediatr Surg 2015;50:1590–1594.CrossRefPubMedGoogle Scholar
  9. 9.
    Dong R, Song Z, Chen G, Zheng S, Xiao XM. Improved outcome of biliary atresia with postoperative high-dose steroid. Gastroenterol Res Pract 2013;2013:902431.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Meyers RL, Book LS, O’Gorman MA, Jackson WD, Black RE, Johnson DG, et al. High-dose steroids, ursodeoxycholic acid, and chronic intravenous antibiotics improve bile flow after Kasai procedure in infants with biliary atresia. J Pediatr Surg 2003;38:406–411.CrossRefPubMedGoogle Scholar
  11. 11.
    Escobar MA, Jay CL, Brooks RM, West KW, Rescorla FJ, Molleston JP, et al. Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy. J Pediatr Surg 2006;41:99–103; discussion 199-103.CrossRefPubMedGoogle Scholar
  12. 12.
    Wang W, Zheng S, Xiao XM. Effect and safety of high-dose steroids in postoperative treatment of biliary atresia. Chin J Pediatr Surg 2006;27:460–463. [In Chinese]Google Scholar
  13. 13.
    Davenport M, Stringer MD, Tizzard SA, McClean P, Mieli-Vergani G, Hadzic N. Randomized, double-blind, placebocontrolled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology 2007;46:1821–1827.CrossRefPubMedGoogle Scholar
  14. 14.
    Vejchapipat P, Passakonnirin R, Sookpotarom P, Chittmittrapap S, Poovorawan Y. High-dose steroids do not improve early outcome in biliary atresia. J Pediatr Surg 2007;42:2102–2105.CrossRefPubMedGoogle Scholar
  15. 15.
    Chung HY, Kak Yuen Wong K, Cheun Leung Lan L, Kwong Hang Tam P. Evaluation of a standardized protocol in the use of steroids after Kasai operation. Pediatr Surg Int 2008;24:1001–1004.CrossRefPubMedGoogle Scholar
  16. 16.
    Petersen C, Harder D, Melter M, Becker T, Wasielewski RV, Leonhardt J, et al. Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia. Am J Gastroenterol 2008;103:712–719.CrossRefPubMedGoogle Scholar
  17. 17.
    Baerg J, Zuppan C, Klooster M. Biliary atresia—a fifteen-year review of clinical and pathologic factors associated with liver transplantation. J Pediatr Surg 2004;39:800–803.CrossRefPubMedGoogle Scholar
  18. 18.
    Shneider BL, Brown MB, Haber B, Whitington PF, Schwarz K, Squires R, et al. A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. J Pediatr 2006;148:467–474.CrossRefPubMedGoogle Scholar
  19. 19.
    Altman RP, Lilly JR, Greenfeld J, Weinberg A, van Leeuwen K, Flanigan L. A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers. Ann Surg 1997;226:348–353; discussion 353-345.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Koga H, Wada M, Nakamura H, Miyano G, Okawada M, Lane GJ, et al. Factors influencing jaundice-free survival with the native liver in post-portoenterostomy biliary atresia patients: results from a single institution. J Pediatr Surg 2013;48:2368–2372.CrossRefPubMedGoogle Scholar
  21. 21.
    Wu ET, Chen HL, Ni YH, Lee PI, Hsu HY, Lai HS, et al. Bacterial cholangitis in patients with biliary atresia: impact on short-term outcome. Pediatr Surg Int 2001;17:390–395.CrossRefPubMedGoogle Scholar
  22. 22.
    Lao OB, Larison C, Garrison M, Healey PJ, Goldin AB. Steroid use after the Kasai procedure for biliary atresia. Am J Surg 2010;199:680–684.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Superina R, Magee JC, Brandt ML, Healey PJ, Tiao G, Ryckman F, et al. The anatomic pattern of biliary atresia identified at time of Kasai hepatoportoenterostomy and early postoperative clearance of jaundice are significant predictors of transplant-free survival. Ann Surg 2011;254:577–585.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Subramaniam R, Doig CM, Bowen J, Bruce J. Initial response to portoenterostomy determines long-term outcome in patients with biliary atresia. J Pediatr Surg 2000;35:593–597.CrossRefPubMedGoogle Scholar
  25. 25.
    Wadhwani SI, Turmelle YP, Nagy R, Lowell J, Dillon P, Shepherd RW. Prolonged neonatal jaundice and the diagnosis of biliary atresia: a single-center analysis of trends in age at diagnosis and outcomes. Pediatrics 2008;121:e1438–e1440.CrossRefPubMedGoogle Scholar
  26. 26.
    Moyer K, Kaimal V, Pacheco C, Mourya R, Xu H, Shivakumar P, et al. Staging of biliary atresia at diagnosis by molecular profiling of the liver. Genome Med 2010;2:33.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Vajro P, Couturier M, Lemonnier F, Odievre M. Effects of postoperative cholestyramine and phenobarbital administration on bile flow restoration in infants with extrahepatic biliary atresia. J Pediatr Surg 1986;21:362–365.CrossRefPubMedGoogle Scholar
  28. 28.
    Kotb MA. Review of historical cohort: ursodeoxycholic acid in extrahepatic biliary atresia. J Pediatr Surg 2008;43:1321–1327.CrossRefPubMedGoogle Scholar
  29. 29.
    Davenport M, Grieve A. Maximizing Kasai portoenterostomy in the treatment of biliary atresia: medical and surgical options. S Afr Med J 2012;102:865–867.CrossRefPubMedGoogle Scholar
  30. 30.
    Willot S, Uhlen S, Michaud L, Briand G, Bonnevalle M, Sfeir R, et al. Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia. Pediatrics 2008;122:e1236–e1241.CrossRefPubMedGoogle Scholar
  31. 31.
    Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 1976;84:304–315.CrossRefPubMedGoogle Scholar
  32. 32.
    Bessho K, Bezerra JA. Biliary atresia: will blocking inflammation tame the disease? Annu Rev Med 2011;62:171–185.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Bezerra JA, Tiao G, Ryckman FC, Alonso M, Sabla GE, Shneider B, et al. Genetic induction of proinflammatory immunity in children with biliary atresia. Lancet 2002;360:1653–1659.CrossRefPubMedGoogle Scholar
  34. 34.
    Narayanaswamy B, Gonde C, Tredger JM, Hussain M, Vergani D, Davenport M. Serial circulating markers of inflammation in biliary atresia—evolution of the post-operative inflammatory process. Hepatology 2007;46:180–187.CrossRefPubMedGoogle Scholar
  35. 35.
    Barnes PJ. Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 1998;94:557–572.CrossRefGoogle Scholar
  36. 36.
    Jazrawi RP, de Caestecker JS, Goggin PM, Britten AJ, Joseph AE, Maxwell JD, et al. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology 1994;106:134–142.CrossRefPubMedGoogle Scholar
  37. 37.
    Miner PB Jr, Sutherland E, Simon FR. Regulation of hepatic sodium plus potassium-activated adenossine triphosphatase activity by glucocorticoids in the rat. Gastroenterology 1980;79:212–221.PubMedGoogle Scholar

Copyright information

© Children's Hospital, Zhejiang University School of Medicine and Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Min-Zhong Zhang
    • 1
    • 2
  • Peng-Cheng Xun
    • 3
  • Ka He
    • 3
  • Wei Cai
    • 1
    • 2
    • 4
  1. 1.Department of Pediatric Surgery, Xinhua hospitalShanghai Jiao Tong University School of MedicineShanghaiChina
  2. 2.Shanghai Key Laboratory of Pediatric Gastroenterology and NutritionShanghaiChina
  3. 3.Department of Epidemiology and Biostatistics, School of Public Health—BloomingtonIndiana UniversityBloomingtonUSA
  4. 4.ShanghaiChina

Personalised recommendations